Fwd: Custom Care Times - April 27, 2007

[Guest guest]

It occurs to me that the reason for all this sudden interest by Big Pharma and their lobbyists against compounding pharmacy's has to do with the growing popularity of bioidentical hormones-which are typically purchased at-you guessed it, compounding pharmacy's! Another effort by Big Pharma at eliminating anything they can't sell themselves...

 

CyndiSee what's free at AOL.com.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

April 27, 2007

Edition 4

 

 

 

 

 

What is P2C2? Why am I receiving this newsletter?

 

Your access to customized, compounded medicines is at risk. Pharmaceutical manufacturers and the FDA are pushing policies that would make it harder for professionals to prescribe, pharmacists to prepare and patients to take compounded medicines.

 

That's why Patients and Professionals for Customized Care, also known as P2C2, is bringing together people who rely on customized, compounded medicines for better health. Whether you are a patient or a physician, a pet owner or a veterinarian, P2C2 will give you the tools you need to keep pharmaceutical manufacturers and the FDA from restricting your access to compounded medicines.

 

With your free membership to P2C2, you'll be receiving Custom Care Times, an electronic newsletter that will keep you up-to-date on the latest news and information that affects your ability to take or prescribe compounded medications.

 

Custom Care Times will let you know when your action is needed, and P2C2 will give you the online tools to let your representative in Congress, officials at the FDA or even relevant members of the media know that you or your patients rely on compounded medicines and that you are committed to making sure they remain available.

 

Our strength is in our numbers. The more patients, physicians, pet owners or veterinarians we have fighting for compounded medicines, the more successful we'll be. Forward this newsletter to your friends. Tell them to join the fight.

 

If you received this newsletter from P2C2 directly, you are already a member. If a friend forwarded this newsletter to you, join P2C2 for free by clicking here.

 

Contact Us info (281) 933-8400

New Report Focuses on the Big Bucks in Pharmaceutical Lobbying

We’ve known for years that big pharmaceutical companies spend tens of millions of dollars every year to influence members of Congress. A recent report that was issued by the Center for Public Integrity showed just how big Pharma’s lobbying efforts have become. According to their report, drug companies and their trade groups spent $155 million from January 2005 through June 2006 and employed about 1,100 lobbyists to do their bidding in each of the past two years (giving the drug companies two lobbyists for every one member of Congress!).

60 Minutes reported further on this subject earlier in the month, exposing one of the worst examples of this money-for-power exchange that goes on between big Pharma lobbyists and members of Congress. The story is a very interesting look at the opposition compounding pharmacists and the patients who benefit from compounded medicines face in our fight to keep our medicines.

To view the piece,

With potential new legislation that would place unnecessary restrictions on compounding being discussed, your support now is more critical than ever. Please check the site often to keep up with the latest events, tell your friends about P2C2 and write your congressional delegation. Thank you for your continued support!

Senator Roberts Clarifies his Position on SDCA

Recently, the International Academy of Compounding Pharmacists and several Kansas pharmacists met with Senator Pat Roberts. In the meeting Senator Roberts clarified his position and stated that he does not support Senator Kennedy and Senator Burr’s draft bill that would place onerous restrictions on compounding pharmacists and limit patients’ access to these medicines. While this is encouraging news, the fight against this potential legislation is far from over. Your continued support is needed to encourage your senators to oppose the legislation.

To contact your senators today,

 

 

 

 

 

 

 

What is SaveMyMedicine.org?

SaveMyMedicine.org is the online home of Patients and Professionals for Customized Care. Here, you'll be able to find the latest news, issue alerts and information on pharmacy compounding and related issues.

 

Compounding in the News Check here often to read the latest news stories on compounding, Wyeth, and other issues.

 

Action Alerts Write a letter to your members of Congress to inform them how compounding affects you and how important it is that your access to compounded medicines is protected.

 

Tell Us Your Story Submit a testimonial that illustrates how pharmacy compounding has made a difference in your life. Your stories will help thousands learn more about the importance of customized care and the impact it has on its patients.

 

 

 

 

P2C2 is an affiliate of the International Academy of Compounding Pharmacists. You are receiving this newsletter because you either (1) signed up for P2C2, (2) used IACP's pharmacy referral service, or (3) used IACP's website to write a comment to FDA opposing Wyeth's citizen petition regarding bioidentical hormones. If you have received this email in error or if you would like to opt-out of all future correspondences, please

 

[Guest guest]

More greed...what else is new....

 

Barbara

 

 

 

It occurs to me that the reason for all this sudden interest by Big Pharma and their lobbyists against compounding pharmacy's has to do with the growing popularity of bioidentical hormones-which are typically purchased at-you guessed it, compounding pharmacy's! Another effort by Big Pharma at eliminating anything they can't sell themselves...

 

Cyndi